Literature DB >> 10422695

Molecular monitoring of human intestinal Bifidobacterium strain diversity.

I Mangin1, Y Bouhnik, N Bisetti, B Decaris.   

Abstract

Predominant Bifidobacterium strains belonging to the intestinal flora of four human volunteers were isolated on selective medium before and after eight days of treatment with oral amoxicillin-clavulanic acid (Augmentin). These antimicrobial agents are known to be strongly active against the genus Bifidobacterium. A fifth volunteer did not receive the antibiotics and was considered as a control. Bifidobacteria were characterized by hybridizing a ribosomal 23S DNA probe onto their EcoRV restriction patterns, and were identified by comparing the ribosomal patterns obtained to collection strains. A total of 17 distinct ribosomal patterns and 23 distinct pattern types were revealed for the 95 isolates tested. Each type characterized was correlated with a specific ribosomal pattern associated with a specific total restriction pattern. Similar-sized molecular bands permitted isolates to be unambiguously discriminated into the species B. longum, B. bifidum, and B. adolescentis. This study enabled us to show considerable strain variability among individuals. Three months after penicillin ingestion, no significant changes were observed in Bifidobacterium flora. Each flora remained relatively stable for strain composition over time, with some slight variations also detected in our control subject.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10422695     DOI: 10.1016/s0923-2508(99)80060-6

Source DB:  PubMed          Journal:  Res Microbiol        ISSN: 0923-2508            Impact factor:   3.992


  5 in total

1.  Bifidobacterial diversity in human feces detected by genus-specific PCR and denaturing gradient gel electrophoresis.

Authors:  R M Satokari; E E Vaughan; A D Akkermans; M Saarela; W M de Vos
Journal:  Appl Environ Microbiol       Date:  2001-02       Impact factor: 4.792

2.  Exploring the Ecological Effects of Naturally Antibiotic-Insensitive Bifidobacteria in the Recovery of the Resilience of the Gut Microbiota during and after Antibiotic Treatment.

Authors:  Chiara Argentini; Leonardo Mancabelli; Giulia Alessandri; Chiara Tarracchini; Margherita Barbetti; Luca Carnevali; Giulia Longhi; Alice Viappiani; Rosaria Anzalone; Christian Milani; Andrea Sgoifo; Douwe van Sinderen; Marco Ventura; Francesca Turroni
Journal:  Appl Environ Microbiol       Date:  2022-06-02       Impact factor: 5.005

3.  Administration of Bacillus coagulans in calves: recovery from faecal samples and evaluation of functional aspects of spores.

Authors:  Barbara Ripamonti; Alessandro Agazzi; Antonella Baldi; Claudia Balzaretti; Carla Bersani; Silvia Pirani; Raffaella Rebucci; Giovanni Savoini; Simone Stella; Alberta Stenico; Cinzia Domeneghini
Journal:  Vet Res Commun       Date:  2009-09-18       Impact factor: 2.459

4.  Long-term changes in human colonic Bifidobacterium populations induced by a 5-day oral amoxicillin-clavulanic acid treatment.

Authors:  Irène Mangin; Christophe Lévêque; Fabien Magne; Antonia Suau; Philippe Pochart
Journal:  PLoS One       Date:  2012-11-27       Impact factor: 3.240

Review 5.  Probiotic-based strategies for therapeutic and prophylactic use against multiple gastrointestinal diseases.

Authors:  Natallia V Varankovich; Michael T Nickerson; Darren R Korber
Journal:  Front Microbiol       Date:  2015-07-14       Impact factor: 5.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.